6 suspended. 6 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Suspended 6 |
| Phase 1 | 2 | Suspended 2 |
| Phase 3 | 1 | Suspended 1 |
Follow Neoplasm Metastasis: new trials by email Literature Review of Neoplasm Metastasis trials Research Report on Neoplasm Metastasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma Systemic therapy, Radiotherapy - Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma | Phase 2 | Suspended | Shandong Cancer Hospital and Institute | 184 | 2025-11-30 | 2026-10-15 |
| Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases Azeliragon, Stereotactic radiosurgery, Corticosteroid - Cancer, Metastasis | Phase 1 / Phase 2 | Suspended | Baptist Health South Florida | 46 | 2023-11-17 | 2026-06-16 |
| A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma Antineoplastic Vaccine, Sargramostim, Pembrolizumab - Advanced Adenocarcinoma, Advanced Malignant Solid Neoplasm | Phase 1 / Phase 2 | Suspended | University of California, Davis | 77 | 2021-01-13 | 2026-06-29 |
| Acelarin First Line Randomised Pancreatic Study Acelarin, Gemcitabine - Pancreatic Acinar Carcinoma, Pancreatic Neoplasms | Phase 2 / Phase 3 | Suspended | The Clatterbridge Cancer Centre NHS Foundation Trust | 328 | 2015-12-01 | 2019-10-29 |
| Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) ZD6126, Placebo - Carcinoma, Renal Cell, Kidney Neoplasms | Phase 2 | Suspended | AstraZeneca | 2003-08-01 | 2011-01-26 | |
| Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma Pegamotecan - Sarcoma, Soft Tissue | Phase 2 | Suspended | Enzon Pharmaceuticals, Inc. | 2003-08-01 | 2012-09-06 |
Neoplasms (2) · Adenocarcinoma (1) · Brain Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Kidney Neoplasms (1) · Pancreatic Neoplasms (1) · Sarcoma (1)
Neoplastic Processes (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Carcinoma (3) · Neoplasms, Glandular and Epithelial (3) · Adenocarcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Endocrine Gland Neoplasms (1)
Adrenal Cortex Hormones (1) · Cancer Vaccines (1) · Colony-Stimulating Factors (1) · Dexamethasone (1) · Gemcitabine (1) · Methylprednisolone (1) · N-acetylcochinol-O-phosphate (1) · NUC-1031 (1) · Radiosurgery (1) · Radiotherapy (1) · azeliragon (1) · pegamotecan (1) · pembrolizumab (1) · sargramostim (1)
AstraZeneca (1) · Baptist Health South Florida (1) · Enzon Pharmaceuticals, Inc. (1) · Shandong Cancer Hospital and Institute (1) · The Clatterbridge Cancer Centre NHS Foundation Trust (1) · University of California, Davis (1)
United States (4) · China (1) · United Kingdom (1)
Daniel H Palmer, BSC, PhD (1) · Minesh Mehta, M.D. (1) · Tianhong Li (1)
P30CA093373 (1)